…, JJ Bochanski, AS Bolton, CT Bosman… - The Astronomical …, 2011 - iopscience.iop.org DANIEL J. EISENSTEIN1,2, DAVID H. WEINBERG3,4, ERIC AGOL5, HIROAkI AIHARA6, CARLOS ALLENDE PRIETO7,8, SCOTT F. ANDERSON5, JAMES A. ARNS9, ´ERIC AUBOURG10,11, STEPHEN BAILEY12, EDUARDO BALBINOT13,14, ROBERT BARkHOUSER15, ... Cited by 2
…, J Vandesompele, CT Wittwer - Clinical …, 2011 - Am Assoc Clin Chem The publication of the minimum information for the publication of real-time quantitative PCR experiments (MIQE) 1 guidelines (1) has turned out to be a defining event in the maturing of quantitative real-time PCR (qPCR) technology. The response from instrument and reagent ... Cited by 1 - Related articles - All 4 versions
[HTML] from nih.gov…, S Shak, EK Rowinsky, LA Xu, CT Harbison… - British journal of …, 2011 - nature.com Although it is accepted that metastatic colorectal cancers (mCRCs) that carry activating mutations in KRAS are unresponsive to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, a significant fraction of KRAS wild-type (wt) mCRCs are also unresponsive to ... Cited by 1 - Related articles - All 5 versions
…, JL Hsu, HH Lee, M Liu, CT Chen… - Nature Cell …, 2011 - nature.com The epithelial–mesenchymal transition (EMT) has recently been linked to stem cell phenotype 1, 2 . However, the molecular mechanism underlying EMT and regulation of stemness remains elusive. Here, using genomic approaches, we show that tumour suppressor p53 has a ... Cited by 9 - Related articles - All 3 versions
CT Ee, LM Breslau… - US Patent 7,944,844, 2011 - Google Patents US 7,944,844 B2 Page 2 US PATENT DOCUMENTS 6,820,132 Bl 11/2004 Puente et al. 6,826,613 Bl 11/2004 Wang et al. 6,847,643 B2 1/2005 Nie 6,850,525 B2 2/2005 Mitsumori et al. 6,873,620 Bl 3/2005 Coveley et al. 6,873,627 Bl 3/2005 Miller et al. 6,996,630 Bl 2/2006 Masaki et ... Related articles - All 3 versions
…, JJ Bochanski, AS Bolton, CT Bosman… - The Astronomical …, 2011 - iopscience.iop.org DANIEL J. EISENSTEIN1,2, DAVID H. WEINBERG3,4, ERIC AGOL5, HIROAkI AIHARA6, CARLOS ALLENDE PRIETO7,8, SCOTT F. ANDERSON5, JAMES A. ARNS9, ´ERIC AUBOURG10,11, STEPHEN BAILEY12, EDUARDO BALBINOT13,14, ROBERT BARkHOUSER15, ... Cited by 2
…, J Vandesompele, CT Wittwer - Clinical …, 2011 - Am Assoc Clin Chem The publication of the minimum information for the publication of real-time quantitative PCR experiments (MIQE) 1 guidelines (1) has turned out to be a defining event in the maturing of quantitative real-time PCR (qPCR) technology. The response from instrument and reagent ... Cited by 1 - Related articles - All 4 versions
[HTML] from nih.gov…, S Shak, EK Rowinsky, LA Xu, CT Harbison… - British journal of …, 2011 - nature.com Although it is accepted that metastatic colorectal cancers (mCRCs) that carry activating mutations in KRAS are unresponsive to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, a significant fraction of KRAS wild-type (wt) mCRCs are also unresponsive to ... Cited by 1 - Related articles - All 5 versions
…, JL Hsu, HH Lee, M Liu, CT Chen… - Nature Cell …, 2011 - nature.com The epithelial–mesenchymal transition (EMT) has recently been linked to stem cell phenotype 1, 2 . However, the molecular mechanism underlying EMT and regulation of stemness remains elusive. Here, using genomic approaches, we show that tumour suppressor p53 has a ... Cited by 9 - Related articles - All 3 versions
CT Ee, LM Breslau… - US Patent 7,944,844, 2011 - Google Patents US 7,944,844 B2 Page 2 US PATENT DOCUMENTS 6,820,132 Bl 11/2004 Puente et al. 6,826,613 Bl 11/2004 Wang et al. 6,847,643 B2 1/2005 Nie 6,850,525 B2 2/2005 Mitsumori et al. 6,873,620 Bl 3/2005 Coveley et al. 6,873,627 Bl 3/2005 Miller et al. 6,996,630 Bl 2/2006 Masaki et ... Related articles - All 3 versions
…, JJ Bochanski, AS Bolton, CT Bosman… - The Astronomical …, 2011 - iopscience.iop.org DANIEL J. EISENSTEIN1,2, DAVID H. WEINBERG3,4, ERIC AGOL5, HIROAkI AIHARA6, CARLOS ALLENDE PRIETO7,8, SCOTT F. ANDERSON5, JAMES A. ARNS9, ´ERIC AUBOURG10,11, STEPHEN BAILEY12, EDUARDO BALBINOT13,14, ROBERT BARkHOUSER15, ... Cited by 2
…, J Vandesompele, CT Wittwer - Clinical …, 2011 - Am Assoc Clin Chem The publication of the minimum information for the publication of real-time quantitative PCR experiments (MIQE) 1 guidelines (1) has turned out to be a defining event in the maturing of quantitative real-time PCR (qPCR) technology. The response from instrument and reagent ... Cited by 1 - Related articles - All 4 versions
[HTML] from nih.gov…, S Shak, EK Rowinsky, LA Xu, CT Harbison… - British journal of …, 2011 - nature.com Although it is accepted that metastatic colorectal cancers (mCRCs) that carry activating mutations in KRAS are unresponsive to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, a significant fraction of KRAS wild-type (wt) mCRCs are also unresponsive to ... Cited by 1 - Related articles - All 5 versions
…, JL Hsu, HH Lee, M Liu, CT Chen… - Nature Cell …, 2011 - nature.com The epithelial–mesenchymal transition (EMT) has recently been linked to stem cell phenotype 1, 2 . However, the molecular mechanism underlying EMT and regulation of stemness remains elusive. Here, using genomic approaches, we show that tumour suppressor p53 has a ... Cited by 9 - Related articles - All 3 versions
CT Ee, LM Breslau… - US Patent 7,944,844, 2011 - Google Patents US 7,944,844 B2 Page 2 US PATENT DOCUMENTS 6,820,132 Bl 11/2004 Puente et al. 6,826,613 Bl 11/2004 Wang et al. 6,847,643 B2 1/2005 Nie 6,850,525 B2 2/2005 Mitsumori et al. 6,873,620 Bl 3/2005 Coveley et al. 6,873,627 Bl 3/2005 Miller et al. 6,996,630 Bl 2/2006 Masaki et ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
